輸入代號或公司名稱後按 Enter
4728

雙美

-3.00 (-0.76%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
392.0011成交張數26.51本益比15.04股價淨值比3.06%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率

營業收入20252,026年增 +11.4%
毛利率202578.4%最新一期
營業利益率202549.3%最新一期
每股盈餘202513.33年增 +6.9%
會計項目走勢2016201720182019202020212022202320242025
銷貨收入+21.2%+59.6%+123.1%+26.2%+21.0%+35.2%+21.5%+7.4%+11.7%
銷貨折讓+214.7%+54.3%
銷貨收入淨額+22.2%+59.9%+123.1%+26.2%+21.0%+35.2%+20.6%+7.6%+11.4%
營業收入合計+22.2%+59.9%+123.1%+26.2%+21.0%+35.2%+20.6%+7.6%+11.4%
銷貨成本-6.8%+21.3%+41.8%+71.1%-8.7%+46.8%+37.1%+19.4%+28.9%
營業成本合計-6.8%+21.3%+41.8%+71.1%-8.7%+46.8%+37.1%+19.4%+28.9%
營業毛利(毛損)+38.8%+74.7%+144.7%+19.3%+27.6%+33.4%+17.8%+5.3%+7.4%
營業毛利(毛損)淨額+38.8%+74.7%+144.7%+19.3%+27.6%+33.4%+17.8%+5.3%+7.4%
推銷費用+89.0%+47.9%+165.2%+4.2%+57.4%-34.7%+38.7%+1.9%+7.6%
管理費用+22.2%+31.8%+32.5%+30.8%+16.6%+16.1%-7.3%+15.0%+5.8%
研究發展費用-39.5%+65.0%+15.9%-22.4%+40.5%-27.0%+59.9%+36.3%+7.8%
營業費用合計+29.4%+42.8%+90.7%+9.0%+42.9%-19.4%+20.1%+8.2%+7.0%
營業利益(損失)+328.5%+373.1%+297.4%+33.2%+10.5%+109.1%+16.5%+3.6%+7.7%
利息收入+114.7%-14.9%+8.3%
其他收入+2.3%+240.1%-60.2%-9.5%-64.1%+4.4%-19.1%+65.5%-15.2%
其他利益及損失淨額-76.8%
財務成本淨額+6.2%-3.7%-52.1%+118.7%+102.3%-17.9%
營業外收入及支出合計+666.9%+209.7%-184.0%-281.5%+59.0%+80.3%-38.2%
稅前淨利(淨損)+413.3%+312.0%+162.0%+47.6%+5.8%+117.4%+17.0%+4.8%+6.4%
所得稅費用(利益)合計+95.7%+172.2%+511.3%+28.2%+12.2%+117.6%+16.6%-3.5%+5.5%
繼續營業單位本期淨利(淨損)+848.1%+351.5%+102.4%+57.5%+3.2%+117.3%+17.2%+8.6%+6.8%
本期淨利(淨損)+848.1%+351.5%+102.4%+57.5%+3.2%+117.3%+17.2%+8.6%+6.8%
國外營運機構財務報表換算之兌換差額-874.1%-147.5%+69.0%
與可能重分類之項目相關之所得稅+69.0%
後續可能重分類至損益之項目:-131.1%+69.0%
其他綜合損益(淨額)-108.0%-140.0%-200.5%+69.0%
本期綜合損益總額+328.4%+94.2%+67.8%+0.3%+122.2%+14.2%+11.0%+7.4%
母公司業主(淨利∕損)+848.1%+351.5%+102.4%+57.5%+3.2%+117.3%+17.2%+8.6%+6.8%
母公司業主(綜合損益)+328.4%+94.2%+67.8%+0.3%+122.2%+14.2%+11.0%+7.4%
基本每股盈餘+933.3%+345.2%+100.7%+57.8%+3.2%+117.3%+17.2%+8.5%+6.9%
繼續營業單位淨利(淨損)+933.3%+345.2%+100.7%+57.8%+3.2%+117.1%+17.2%+8.6%+6.8%
稀釋每股盈餘+57.8%+3.2%+117.1%+17.2%+8.6%+6.8%
銷貨退回-76.8%-100.0%-100.0%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-56.3%-193.5%-86.3%-100.0%
不重分類至損益之項目:-193.2%-86.3%-100.0%
預期信用減損損失(利益)+117.7%-196.5%-259.8%
確定福利計畫之再衡量數-300.0%-100.0%
與不重分類之項目相關之所得稅-337.3%-100.0%
備供出售金融資產未實現評價損益-100.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。